Amyloidosis pp 241-243 | Cite as

Degradation of AA-Amyloid, Clinical Experience: An Introduction

  • Otto Wegelius
  • Tom Törnroth


The Fourth Department of Medicine in Helsinki has beside general internal medicine the responsibility for rheumatology and nephrology. Patients with rare disorders like amyloidosis and patients waiting for kidney transplantation are remitted to this department from the whole country. An accumulation of amyloid diseased patients demands efforts of both research and treatment. The frequency of amyloidosis in rheumatic patients at this university department is strikingly higher than in Rheumatism Foundation Hospital in Heinola. The prognosis of reactive amyloidosis among rheumatic patients is known to be poor. The Finnish material reported by us at the meeting in Portugal showed the same. In a cumulative survival study only a few patients survived over 15 years. These few patients with good prognosis might give a clue about the beneficial forces responsible for regression of the disease. Discovery of these mechanisms could lead us to a successful treatment.


Rheumatic Patient Amyloid Fibril Degrading Activity Renal Amyloidosis Membranous Glomerulonephritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wegelius, O., Wafiri, F., Falck, H., and Tornroth, T., Follow-up Study of Amyloidosis Secondary to Rheumatic Diseases, in: Amyloid and Amyloidosis (G. G. Glenner, P. P. Costa, and F. de Freitas, eds.), Amsterdam, Excerpta Medica, 183–199 (1980).Google Scholar
  2. 2.
    Wegelius, O., The Resolution of Amyloid Substance, Acta, Med. Scand., 212: 273–275 (1982).CrossRefGoogle Scholar
  3. 3.
    Kukhlback, B., and Wegelius, O., Secondary Amyloidosis, A Study of Clinical and Pathological Findings, Acta Med. Scand., 180: 737 (1966).CrossRefGoogle Scholar
  4. 4.
    Falck, H. Tornroth, T., Skrifvars, B., and Wegelius, O., Resolution of Renal Amyloidosis Secondary to Rheum1atoid Arthritis, Acta Med. Scand., 205: 651–656 (1979).PubMedCrossRefGoogle Scholar
  5. 5.
    Tornroth, T., The Fate of Subepithelial Deposits in Acute Poststreptococcal Glomerulonephritis, Lab. Invest., 35: 461 (1976).PubMedGoogle Scholar
  6. 6.
    Tornroth, T., Falck, H. M., and Wegelius, O., Nonfibrillar Glomerular Deposits in Resolving Renal Amyloidosis, in: Amyloidosis E.A.R.S. ( C. R. Tribe and P. A. Bacon, eds.), John Wright and Sons, Ltd., Bristol (1983).Google Scholar
  7. 7.
    Wegelius, O. Teppo, Anna-Maija, and Maury, C. P. J., Reduced Amyloid- A-Degrading Activity in Serum in Amyloidosis Associated with Rheumatoid Arthritis, Br. Med. J., 287: 617–619 (1982).CrossRefGoogle Scholar
  8. 8.
    Teppo, Anna-Maija, Maury, C. P. J., and Wegelius, O., Characteristics of the Amyloid A Fibril-Degrading Activity of Human Serum, Scand. J. Immunol., 16: 309–314 (1982).Google Scholar
  9. 9.
    Falck, H., Maury, C. P. J., Teppo, Anna-Maija, and Wegelius, O., Correlation of Persistently High Serum Amyloid-A-Protein and C-Reac tive Protein Concentrations with Rapid Progression of Secondary Amyloidosis, Br. Med. J., 286: 1391–1393 (1983)CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Otto Wegelius
    • 1
  • Tom Törnroth
    • 1
  1. 1.Fourth Department of MedicineHelsinki University Central HospitalHelsinkiFinland

Personalised recommendations